Significant Dialysis Development
(Houston Methodist) Eric Peden, M.D., chief of vascular surgery at Houston Methodist DeBakey Heart& Vascular Center, was the first surgeon in the US to perform minimally-invasive surgery to create access for dialysis patients with severe kidney disease. The WavelinQ endoAVF System by Becton Dickson allows vascular surgeons to create a connection between an artery and vein using a technique involving magnets. The system was recently approved by the Food and Drug Administration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2018 Category: International Medicine & Public Health Source Type: news
Wright Medical shares rise on Q2 earnings Beat
Shares in Wright Medical (NSDQ:WMGI) rose today in pre-market trading after the medical device maker beat expectations on Wall Street with its second quarter results.
The Amsterdam-based company posted losses of $67.7 million, or 64¢ per share, on sales of $205.4 million for the three months ended July 1, seeing losses grow 64.5% while sales grew 14.3% compared with the same period last year.
Adjusted to exclude one-time items, losses per share were 3¢, just ahead of the 6¢ loss-per-share consensus on The Street, where analysts were looking for sales of $196.8 million, which the company also topped.
“We produced ...
Source: Mass Device - August 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat wrightmedical Source Type: news
Potrero Smartens up Its Catheter to Predict Diseases
Potrero Medical is hoping to use and machine learning to help predict diseases. To help with this goal, the San Francisco, CA-based company has raised $26.6 million in a series C round. The financing was led by China-focused healthcare investment firm GT Healthcare Capital Partners and Silicon Valley-based Sonder Capital.
The company has a product on the U.S. market, the Accuryn Monitoring System, which turns a traditional urinary catheter into a smart sensor that helps to accurately monitor a patients’ vital signs in real-time.
The financing proceeds will be used to further commercialize Accuryn and will also be used to...
Source: MDDI - July 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news
Urinary monitor dev Potrero Medical closes $27m Series C
Predictive health company Potrero Medical said yesterday it closed a $26.6 million Series C funding to help support commercialization of its flagship Accuryn monitoring system.
The San Francisco-based company’s Accuryn system is designed to use urinary catheters as diagnostic tools. The device provides real-time measurements of intra-abdominal pressure, urine output and core body temperature and can be integrated into hospital EMR systems, the company said.
Financing in the round was led by GT Healthcare Capital Partners and Sonder Capital, Potrero Medical said.
“We are excited to be a part of Potrero Medical̵...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Urology Potrero Medical Source Type: news
FlexDex, Inc. Appoints New Vice President, Research and Development and Vice President, International Sales and Marketing
BRIGHTON, Mich., June 06, 2018 -- (Healthcare Sales & Marketing Network) -- FlexDex, Inc. (FlexDex or Company), a medical device company that is developing a platform of articulating laparoscopic instruments for minimally invasive surgery, announced to... Devices, Surgery, Personnel FlexDex, laparoscope, laparoscopic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 6, 2018 Category: Pharmaceuticals Source Type: news
Less Morbidity, Lower Costs Tied to MIS in Cervical Cancer
(MedPage Today) -- But minimally invasive surgery also linked to decreased survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 5, 2018 Category: Hematology Source Type: news
Intuitive Surgical wins expanded clearance for da Vinci SP
Intuitive Surgical (NSDQ:ISRG) said today that it won 510(k) clearance from the FDA for a new indication for its da Vinci SP robot-assisted surgery device and revealed plans to pursue other indications for the single-port device.
Initially cleared in April 2014 for urological procedures, the da Vinci SP’s newest indication is for procedures requiring very narrow access from a single small incision. Sunnyvale, Calif.-based Intuitive said it plans to ask the FDA to clear transoral, transanal, and extraperitoneal applications for the SP device.
“The da Vinci SP is the latest in our integrated product family t...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Regulatory/Compliance Robotics Surgical Urology Wall Street Beat Intuitive Surgical Source Type: news
DePuy Synthes launches Global Unite reverse fracture shoulder implant
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today announced the launch of the Global Unite reverse fracture shoulder implant designed for shoulder reconstruction procedures following complex fractures in patients with grossly deficient rotator cuffs.
The newly launched system is intended to provide increased flexibility for securely reattaching the bone to the implant, which DePuy Synthes said is important for healing and function, and to allow for biological fixation to the implant stem.
“I find that especially in my older patients whose bone quality doesn’t allow me to use the plates and scre...
Source: Mass Device - May 22, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Orthopedics depuysynthes johnsonandjohnson Source Type: news
Intuitive Surgical touts inguinal hernia study
Intuitive Surgical (NSDQ:ISRG) touted a 1,254-patient study today showing that patients who underwent robotic-assisted surgery using the da Vinci system to repair an inguinal hernia had fewer complications after 30 days compared to patients who had open surgery.
The study, published in Hernia: The World Journal of Hernia and Abdominal Wall Surgery, was characterized by Intuitive as the largest multi-center comparative study of robotic-assisted and open surgery for inguinal hernia repair.
None of the patients in the robotic-assisted surgery group returned for reoperations related to the inguinal hernia repair procedure af...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Robotics Surgical Wall Street Beat Intuitive Surgical Source Type: news
Intuitive Dominates in its 1Q18 Earnings
The competition might be mounting in the surgical robotics space, but it isn’t having much of an impact on Intuitive Surgical - yet. The Sunnyvale, CA-based company managed to beat out Wall Street analysts' expectations in its latest quarterly earnings.
Intuitive brought in about $848 million in the first quarter of 2018. This was a 25% increase over the $680 million the company earned this time last year.
“We had a strong first quarter in pursuit of our mission with customer use of our systems at the top of our growth range, continuing momentum in new system placements, and stepwise progress in the development of mark...
Source: MDDI - April 19, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Intuitive Surgical shares up on Street-beating Q1
Shares in Intuitive Surgical (NSDQ:ISRG) have risen in after-hours trading today after the robotic surgery giant posted first quarter 2018 earnings that beat expectations on Wall Street.
The Sunnyvale, Calif.-based company posted profits of $287.3 million, or $2.44 per share, on sales of $847.5 million for the three months ended March 31, seeing the bottom line grow 58.9% while sales grew 24.7% compared with the same period last year.
After adjusting for one-time items, earnings per share were still at $2.44, well ahead of the the $2.09 consensus on The Street, where analysts were looking for sales of $783.3 million.
Int...
Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Robotics Wall Street Beat Intuitive Surgical Source Type: news
Vicarious Surgical comes out of stealth with $17m Series A for VR-based robot-assisted surgery device
Vicarious Surgical came out of stealth mode today by announcing a nearly $17 million Series A round for the virtual reality-augmented robot-assisted surgery platform it’s developing.
Cambridge, Mass.-based Vicarious, which first reported a $2.4 million raise in January 2016 and another $800,000 in October of that year, opened the Series A round in January with a nearly $13 million installment. Today the company said Khosla Ventures and Innovation Endeavors led the $16.8 million Series A, joined by Gates Ventures, AME Cloud Ventures and Salesforce founder & CEO Marc Benioff. The proceeds are earmarked for continu...
Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Robotics Wall Street Beat Vicarious Surgical Source Type: news
Unexpected Outcome in Hysterectomy Study
(MedPage Today) -- More cancer recurrences, worse survival with minimally invasive surgery (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 27, 2018 Category: Hematology Source Type: news
MIS device startup Human Xtensions wins FDA nod for HandX device
Minimally invasive surgery device start up Human Xtensions said today it won FDA 510(k) clearance for its HandX device.
The HandX device is a light-weight, handheld device designed to translate a surgeon’s natural hand motions into more complex movements inside the patient, the Israel-based company said.
The device is part of a series of electromechanically-simplified surgical systems the company is developing in a modular format, Human Xtension said. The company also produces smart 5mm surgical tools designed to pass through trocars to improve access and freedom of movement in MIS procedures.
“We believe in te...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Surgical humanxtensions Source Type: news
Does robotic telesurgery have a future?
Although many have experimented with remote “telesurgery,” are the conditions right for commercial companies to start making an investment in a remote robotic surgical future?
Although the idea of telesurgery — performing specialized procedures with robot-assisted surgical tools from a remote location — dates back to the very first research into medical robotics, the technology has yet to make a significant commercial impact.
Robotic surgery is one of the hottest fields in medtech, as a raft of new entrants expand the possibilities for minimally invasive surgery. But thus far, commercialized systems are operated in...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Robotics Surgical Corindus Vascular Robotics Source Type: news
